Use of intravenous immune globulin in the ICU: A retrospective review of prescribing practices and patient outcomes

Transfusion Medicine

Volumn 20, Issue 6, 2010, Pages 403-408

  Foster, R ^a   Suri, A ^b   Filate, W ^b   Hallett, D ^b   Meyer, J ^c   Ruijs, T ^d   Callum, J L ^e   Sutton, D ^f   Mehta, S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c ST JOSEPH S HEALTH CENTRE   (Canada)

^d William Osler Health Center   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Critical care; Intensive care unit; Intravenous immune globulin

Indexed keywords

IMMUNOGLOBULIN;

ACUTE KIDNEY FAILURE; CANADA; CLINICAL PRACTICE; CLINICAL TRIAL; COMMUNITY HOSPITAL; FEVER; GUILLAIN BARRE SYNDROME; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MULTICENTER STUDY; NECROTIZING FASCIITIS; RETROSPECTIVE STUDY; REVIEW; STATISTICS; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ACUTE KIDNEY INJURY; EPIDERMAL NECROLYSIS, TOXIC; FASCIITIS, NECROTIZING; FEVER; GUILLAIN-BARRE SYNDROME; HOSPITALS, COMMUNITY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INTENSIVE CARE; INTENSIVE CARE UNITS; ONTARIO; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79952278691     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2010.01022.x     Document Type: Article

References (24)

1. Alejandria, M.M., Lansang, M.A., Dans, L.F. & Mantaring, J.B.V. (2003) Intravenous immunoglobulin for treating sepsis and septic shock (Cochrane Review). In: The Cochrane Library. Update Software, Oxford.
2. Anderson, D., Ali, K., Blanchette, V. et al.(2007) Guidelines on the use of intravenous immuneglobulin for hematologic conditions. Transfusion Medicine Review, 21(Suppl 1), S9-S56.
3. Canadian Blood Services. (2007) Plasma Protein Product Information URL www.bloodservices.ca. (Accessed 2009).
4. Chen, C., Danekas, L., Ratko, T., Vlasses, P. & Matuszewski, K. (2000) A multicenter drug use surveillance of intravenous immunoglobulin utilization in US academic health centers. The Annals of Pharmacotherapy, 34, 295-299.
5. Darabi, K., Abdel-Wahab, O. & Dzik, W. (2006) Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature. Transfusion, 46, 741-753.
6. Darenberg, J., Ihendyane, N., Sjolin, J., Aufwerber, E., Haidl, S., Follin, P., Andersson, J. & Norrby-Teglund, A. (2003) Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clinical Infectious Diseases, 37, 333-340.
7. Feasby, T., Banwell, B., Benstead, T. et al.(2007) Guidelines on the use of intravenous immune globulin for neurologic conditions. Transfusion Medicine Review, 21(Suppl 1), S57-S107.
8. Final Report of a National Survey on IVIG utilization: Current Practices Regarding the Stocking, Issuing, Preparation, Documentation, and infusion of IVIG across Canada, August 2004.
9. French, L.E., Trent, J.T. & Kerdel, F.A. (2006) Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. International Immunopharmacology, 6, 543-549.
10. Hanna, K., Poulin-Costello, M., Preston, M. & Maresky, M. (2003) Intravenous immune globulin use in Canada. Canadian Journal of Clinical Pharmacology, 10, 11-16.
11. Hughes, R.A., Raphael, J.C., Swan, A.V. & Van Doorn, P.A. (2006) Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database Syst Rev, CD002063.
12. Kaul, R., McGeer, A., Norrby-Teglund, A., Schwartz, B., O'Rourke, K., Talbot, J. & Low, D.E. (1999) Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome - a comparative observational study. The Canadian Streptococcal Study Group. Clinical Infectious Diseases, 28, 800-807.
13. Laupland, K. (2002) Polyclonal intravenous immunoglobulin for the prophylaxis and treatment of infection in critically ill adults. Canadian Journal of Infectious Diseases, 13, 100-106.
14. Laupland, K.B., Kirkpatrick, A.W. & Delaney, A. (2007) Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Critical Care Medicine, 35, 2686-2692.
15. Mehta, S., McGeer, A., Low, D.E., Hallett, D., Bowman, D.J., Grossman, S.L. & Stewart, T.E. (2006) Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICU. Chest, 130, 1679-1686.
16. Morbidity and Mortality Weekly Report. (1999) Renal insufficiency and failure associated with immune globulin intravenous therapy - United States, 1986-1998. Morbidity and Mortality Weekly Report, 48, 518-521.
17. Mydlarski, P.R., Ho, V. & Shear, N.H. (2006) Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology. Journal of Cutaneous Medicine and Surgery, 10, 205-221.
18. Norrby-Teglund, A., Muller, M., McGeer, A., Gan, B.S., Guru, V., Bohnen, J., Thulin, P. & Low, D.E. (2005) Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scandinavian Journal of Infectious Disease, 37, 166-172.
19. Pi, D. & Petraszko, T. (2002) Chapter 1: IVIG Supply and Cost. In: IVIG Utilization Management Handbook (1st edn), 1-3. Provincial Blood Coordinating Office, British Columbia, Canada.
20. Selin, S. (2002) Chapter 2: IVIG Utilization in British Columbia. In: IVIG Utilization Management Handbook (1st edn), 4-7. Provincial Blood Coordinating Office, British Columbia, Canada.
21. Sher, G., Chiavetta, G.A., Newman, A., Gula, C. & Boyce, C. (2003) Summary of national data on Canadian IVIG usage. Canadian Blood Services, 3 October 2003.
22. Shortt, R., Gomez, M., Mittman, N. & Cartotto, R. (2004) Intravenous immunoglobulin does not improve outcomes in toxic epidermal necrolysis. Journal of Burn Care and Rehabilitation, 25, 246-255.
23. Turgeon, A.F., Hutton, B., Fergusson, D.A., McIntyre, L., Tinmouth, A.A., Cameron, D.W. & Hébert, P.C. (2007) Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Annals of Internal Medicine, 146, 193-203.
24. Werdan, K. (2001) Intravenous immunoglobulin for prophylaxis and therapy of sepsis. Current Opinion in Critical Care, 7, 354-361.